Increased colonic adenylate cyclase activity in active ulcerative colitis

Area of Science:

• Gastroenterology
• Molecular Biology
• Cellular Physiology

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by diarrhea.
• The precise mechanisms driving diarrhea in active UC remain incompletely understood.
• Adenylate cyclase activity in the colon is a key regulator of cellular signaling.

Purpose of the Study:

• To investigate the role of colonic adenylate cyclase activity in the pathogenesis of diarrhea in ulcerative colitis.
• To compare enzyme activity between active UC patients, UC patients in remission, and healthy controls.

Main Methods:

• Measurement of basal and stimulated adenylate cyclase activity in colonic mucosal biopsies.
• Utilized activators including sodium fluoride, vasoactive intestinal polypeptide (VIP), and GTPγS.
• Assessed the effect of Prostaglandin E2 (PGE2) on enzyme activity.

Main Results:

• Basal adenylate cyclase activity was significantly higher (two-fold) in active UC patients compared to normal subjects or UC patients in remission.
• Enzyme activity was similarly stimulated by NaF, VIP, and GTPγS across all groups.
• Prostaglandin E2 stimulated enzyme activity in normal, shigellosis, and remission UC groups, but not in active UC patients.

Conclusions:

• Elevated colonic adenylate cyclase activity in active UC may contribute to diarrhea.
• This stimulation might be secondary to enhanced colonic prostanoid synthesis.
• Dysregulation of this signaling pathway is implicated in UC pathogenesis.